Michael Thomas

Medical education professional

[PeerView @PeerView]

Remember to join us tomorrow, June 16 at 7:00 PM EDT for our #HIV virtual workshop: https://t.co/hG2JSGcsV9 #InfectiousDisease

[PeerView @PeerView]

Thank you to Dr. Vinod Ravi (@vinodravi) and their co-chair for sharing their expertise during #SARCtrials on Friday!

🎥 Catch the on-demand replay here: https://t.co/SuYs0POSY7

Special thanks to @EMDGroup for educational grant support #CME #MedEd

[PeerView @PeerView]

Test your knowledge in this question-based #CME #AAPA activity, "#AlloHCT: Engineered Cell Therapy for Improving Transplant Outcomes and Reducing #GVHD" - https://t.co/CiMJEdMP3J

[PeerView @PeerView]

Thank you to Drs. Moore (@DrKatyMoore), Liu, and Oaknin (@AnaOaknin) for sharing their expertise during #ASCO26 on Friday!

🎥 Catch the on-demand replay here: https://t.co/T87mowZVv6

Special thanks to @AstraZeneca, @DaiichiSankyoUS and @Merck for educational grant support, and @GYNCancer for collaboration #CME #MedEd

[PeerView @PeerView]

Appreciation to @skopetz, @CathyEngMD, and @mgfakih for a thoughtful and impactful session at #ASCO26 on Friday!

🎬 Replay available here: https://t.co/ELAvsUUQhA

Thank you to @bmsnews, @ExelixisInc, @JNJNews, and @TaihoOncology, for grant support, and @CCAlliance for collaboration #CME #MedEd

[PeerView @PeerView]

🙌 Big thanks to @SagarLonialMD, @NBahlis & @DrKrinaPatel for an engaging discussion at #ASCO26 on Friday! If you missed us live, watch the replay here: https://t.co/OdbBuFbC1R

Appreciation to @bmsnews for grant support and @HealthTree for collaboration #CME #MedEd

[PeerView @PeerView]

The multiple myeloma cure era is at hand—hyperbole or reality? 🤔

Sagar Lonial, MD, FACP (@SagarLonialMD) discusses how advances in modern myeloma therapy are converging with promising new CELMoD data presented at #ASCO26—and what these findings could mean for optimizing patient outcomes—in an interview with Carmine DeLuca, PeerView’s Chief Medical Officer (@cvdelucaPVI).

Missed us in Chicago? Explore rebroadcasts of our symposia at ASCO—including a multiple myeloma program led by Dr. Lonial—here: https://t.co/jiqPOdqiMA

[PeerView @PeerView]

Watch Vinod Ravi, MD, MS, MBA & Co-Chair discuss the latest TGCT care updates on integrating CSF1R inhibitors in clinical practice during #SARCtrials - to participate, visit: https://t.co/SuYs0POSY7 https://t.co/EF50zmHO0s

[OncoDaily @oncodaily]

Excited to Discuss Rapidly Evolving Landscape of MIBC Treatment - Shilpa Gupta (@shilpaonc)

@SpeakJen

https://t.co/3zcBoJFaE6

#OncoDaily #Oncology #Cancer #Health #Medicine

[Colorectal Cancer Alliance @CCAlliance]

New treatment options and updated guidelines are improving colorectal cancer outcomes. Tanios Bekaii-Saab, MD (@GIcancerdoc) offers guidance on therapeutic sequencing strategies in this #MedEd activity, in collaboration with @PeerView 👉 https://t.co/YCojo1vWyA

[Virgil Simons @vhsimons]

Next Wednesday we speak with Dr. Elisabeth Heath about the future of prostate cancer care.
Tune in from 4:00 to 5:00PM CET (10:00AM EST) at:
Barcelona Radio: 102.5FM - La Marina Cat
Internet: https://t.co/T3ae5R6nF6
YouTube: https://t.co/7UEW61suiO

[HopeForStomachCancer @StoCANcer]

When treatment decisions are grounded in real evidence, and the patient experience, outcomes improve. We're proud to partner with @PeerView at #ASCO26 for a live symposium on advancing gastric & GEJ cancer care on May 30th. Graphic for details.

Register: https://t.co/F6jAArEODO

[Head and Neck Cancer Alliance @hncalliance]

Reminder to join our partners @PeerView next week at #ASCO26 on 5/29 at 7:00 PM CDT for a live #HNSCC symposium. Don’t miss insights on immunotherapy and novel approaches: https://t.co/18KKC0m2ae #MedEd

[HopeForStomachCancer @StoCANcer]

Biomarker-driven care. Immunotherapy. Real-world outcomes. These aren't just buzzwords, they're what better patient care looks like.

We're joining @PeerView at #ASCO26 to bring that conversation to life.

Hear from leading experts on 5/30 at 7 PM CDT: https://t.co/w69Qlo1WPb

[HealthTree Foundation @HealthTree]

Don’t miss this live in person + virtual event with @PeerView! The Drs. Sagar Lonial (@SagarLonialMD), Nizar Bahlis, & Krina Patel (@DrKrinaPatel) are breaking down innovative strategies for RRMM care and the evolving role of #CELMoDs during #ASCO26.
🔗 https://t.co/Fl3rSFiD8d

[FdtnForWomensCancer @GYNCancer]

How are antibody-drug conjugates reshaping gynecologic cancer care? Join @PeerView at #ASCO26 on 5/29, 7 PM CDT for a live symposium with @DrKatyMoore & faculty on the latest data and practical strategies for safe, effective use. Register: https://t.co/V9xHCnACiH #Oncology #MedEd

[HopeForStomachCancer @StoCANcer]

Gastric & GEJ cancer treatment is evolving fast and patients deserve care that reflects it. Join us and @PeerView at #ASCO26 for a live symposium on biomarker-driven care, targeted therapies, and immunotherapy. 5/30 at 7 PM CDT in Chicago or virtually. https://t.co/w69Qlo1WPb

[Head and Neck Cancer Alliance @hncalliance]

Reminder to join our partners @PeerView next week at #ASCO26 on 5/29 at 7:00 PM CDT for a live #HNSCC symposium. Don’t miss insights on immunotherapy and novel approaches: https://t.co/18KKC0m2ae #MedEd

[HealthTree Foundation @HealthTree]

Excited to partner with @PeerView to bring the MoD Squad to #ASCO26! Join Drs. @SagarLonialMD, Nizar Bahlis, & @DrKrinaPatel on 5/29 at 7 PM CDT to explore
#CELMoDs in #MultipleMyeloma.
Join us live in Chicago or virtually: https://t.co/Fl3rSFiD8d

[Shilpa Gupta @shilpaonc]

Excited to discuss rapidly evolving landscape of MIBC treatment with the amazing @MattGalsky @siadaneshmand @ASCO #ASCO26 @PeerView
on Saturday, May 30
Please register
👇👇